For all those who have been harmed from taking a drug which was not well-tested or simply turned out to be dangerous, their only recourse may be to file a lawsuit against the manufacturer of the drug in order to obtain compensation for their injuries. Byetta is one such drug; research has shown that Byetta may bring potential risks of serious illness among those taking the drug. Byetta was developed to treat Type 2 diabetes, along with diet and exercise by controlling blood sugar in the body when it becomes too high.
Byetta is taken twice daily in injections, prior to breakfast and dinner. Thyroid cancer, pancreatitis and pancreatic cancer are all potential risks associated with Byetta. In fact, some studies show a six-fold increase in the risks of pancreatitis, a three-fold increase in the risks of pancreatic cancer and a two-fold increase in the risks of Byetta thyroid cancer. For those who have suffered serious harm from this Type 2 diabetes drug, Byetta legal representation may be in order.
Byetta Statute of Limitations
While most states operate under a two-year statute of limitations (Texas included) others have a one, three, four, five or six year statute. In many cases the statute of limitations begins when a drug is recalled. Byetta has not yet been recalled so assessing when the statute begins may require legal assistance. Even if the statute of limitations has passed, a knowledgeable Byetta thyroid cancer attorney could ensure you receive compensation for your injuries, including medical expenses, lost wages and pain and suffering.
Byetta Thyroid Cancer Damages
Those who have been more severely harmed from Byetta may be entitled to a larger settlement however no matter the level of injury you have sustained. It can still be beneficial to discuss your Byetta case with a knowledgeable attorney who will always have your best interests at heart. It is believed that Byetta thyroid cancer lawsuits will claim a failure to warn as there were indications that Byetta had some risks involved early on—risks which were not properly relayed to consumers or to prescribing physicians. Only one small clinical trial was conducted prior to releasing Byetta, and had not the FDA mandated stronger labeling three separate times, it is unlikely Byetta’s warning label would have reflected the adverse reports from users.